These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Peritoneal effects of intravenous iron sucrose administration in rats. Breborowicz A; Polubinska A; Breborowicz M; Simon M; Wanic-Kossowska M; Oreopoulos DG Transl Res; 2007 Jun; 149(6):304-9. PubMed ID: 17543848 [TBL] [Abstract][Full Text] [Related]
23. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats. Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803 [TBL] [Abstract][Full Text] [Related]
24. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Williams JD; Topley N; Craig KJ; Mackenzie RK; Pischetsrieder M; Lage C; Passlick-Deetjen J; Kidney Int; 2004 Jul; 66(1):408-18. PubMed ID: 15200450 [TBL] [Abstract][Full Text] [Related]
25. In vivo model to study the biocompatibility of peritoneal dialysis solutions. Wieczorowska-Tobis K; Korybalska K; Polubinska A; Radkowski M; Breborowicz A; Oreopoulos DG Int J Artif Organs; 1997 Dec; 20(12):673-7. PubMed ID: 9506780 [TBL] [Abstract][Full Text] [Related]
26. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide? Douma CE; de Waart DR; Struijk DG; Krediet RT Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660 [TBL] [Abstract][Full Text] [Related]
27. Glucose and mannitol have different effects on peritoneal morphology in chronically dialyzed rats. Styszynski A; Kwiatkowska B; Wieczorowska-Tobis K; Breborowicz A; Oreopoulos DG Adv Perit Dial; 2003; 19():15-9. PubMed ID: 14763027 [TBL] [Abstract][Full Text] [Related]
28. Long-term effects of glycylglycine peritoneal dialysis solution with neutral pH on peritoneum in rats. Wieczorowska-Tobis K; Korybalska K; Polubińska A; Radkowski M; Breborowicz A; Montagne A; Oreopoulos DG Adv Perit Dial; 1997; 13():42-6. PubMed ID: 9360649 [TBL] [Abstract][Full Text] [Related]
29. Effects of peritoneal hyaluronidase treatment on transperitoneal solute and fluid transport in the rat. Carlsson O; Rosengren BI; Rippe B Acta Physiol Scand; 2000 Mar; 168(3):371-6. PubMed ID: 10712574 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the effect of uremia on peritoneal permeability in an experimental model of continuous ambulatory peritoneal dialysis in anephric rats. Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos D Adv Perit Dial; 1999; 15():32-5. PubMed ID: 10682068 [TBL] [Abstract][Full Text] [Related]
31. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions. Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223 [TBL] [Abstract][Full Text] [Related]
32. High peritoneal residual volume decreases the efficiency of peritoneal dialysis. Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469 [TBL] [Abstract][Full Text] [Related]
33. Amphotericin B does not increase peritoneal fluid removal. Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B Adv Perit Dial; 1998; 14():3-10. PubMed ID: 10649681 [TBL] [Abstract][Full Text] [Related]
34. Effects of bicarbonate dialysis solution on peritoneal transport in rats. Suzuki K; Khanna R; Nolph KD; Moore HL; Twardowski ZJ Adv Perit Dial; 1996; 12():24-6. PubMed ID: 8865866 [TBL] [Abstract][Full Text] [Related]
35. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation. Park MS; Kim JK; Holmes C; Weiss MF Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610 [TBL] [Abstract][Full Text] [Related]
37. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model. Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576 [TBL] [Abstract][Full Text] [Related]
38. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial. Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526 [TBL] [Abstract][Full Text] [Related]
39. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution. Günal AI; Celiker H; Akpolat N; Ustündag B; Duman S; Akcicek F Perit Dial Int; 2002; 22(3):301-6. PubMed ID: 12227386 [TBL] [Abstract][Full Text] [Related]
40. [Influence of hyaluronan on peritoneal permeability for macromolecules in vitro]. Grzelak T; Czyzewska K; Szary B Pol Arch Med Wewn; 2005 Dec; 114(6):1163-71. PubMed ID: 16789485 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]